Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.47 -0.02 (-4.08%)
At close: Aug 20, 2026 · 4:00 PM EDT

Pasithea Therapeutics (KTTA) Shares Outstanding (Entity) (2020 - 2026)

Pasithea Therapeutics (KTTA) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 62.54 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 399.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 113.02 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 133.73 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 218.28 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 575.47 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 252.88 Mn
10 Pasithea Therapeutics 15.13 Mn 15.13 Mn - 33.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.94 Mn
Dec 31, 2025 7.03 Mn
Sep 30, 2025 7.44 Mn
Jun 30, 2025 5.64 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.04 Mn
Jun 30, 2024 1.04 Mn
Mar 31, 2024 1.04 Mn
Dec 31, 2023 1.04 Mn
Sep 30, 2023 1.04 Mn
Jun 30, 2023 1.31 Mn
Mar 31, 2023 1.31 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 1.33 Mn
Jun 30, 2022 1.33 Mn
Mar 31, 2022 1.15 Mn
Dec 31, 2021 520,233.00
Sep 30, 2021 447,810.00
Jun 30, 2021 412,919.00